Educational; not medical advice. Supptide doesn't sell, source or recommend GHK-Cu, and this article gives no dosing. Last reviewed 27 October 2026.
GHK-Cu, often called "copper peptide", shows up in skincare and, increasingly, in injectable form. Here's what the research supports and where it runs out.
What it is
GHK is a three-amino-acid peptide (glycyl-L-histidyl-L-lysine) found naturally in human plasma, saliva and urine. Its levels decline with age. It binds copper, and the copper complex is what's usually called GHK-Cu [1].
What the lab and animal research shows
In cell and animal studies, GHK has been reported to:
- stimulate both the building and the breakdown of collagen and other skin-matrix components;
- attract the cells involved in repair;
- speed wound healing in several animal species [1, 2].
A 2026 review of the full evidence agrees that preclinical data "consistently support" effects on the skin's structural matrix [3].
What the human research shows
This is where the evidence thins out:
- Topical use (creams and serums). Reviews describe controlled human studies reporting improvements in selected skin measures: wrinkles, hydration, elasticity, density and pigmentation [4]. But many of those trials are small. Results also seem to depend on the specific product and formulation, so one GHK-Cu cream can't be assumed to work like another [4].
- The overall judgement. A 2026 evidence-mapping review concluded that the clinical evidence "remains sparse", and that GHK-Cu "should be regarded as a promising but unproven" agent rather than a clinically validated one [3].
- What we couldn't find. We didn't find a large, independent, randomized controlled trial of a topical GHK-Cu product with published results.
Injectable GHK-Cu is a different matter:
- There are no controlled human data on it for skin.
- FDA lists "GHK-Cu (for injectable routes of administration)" among bulk substances for drug compounding that were nominated and later withdrawn. FDA notes that compounded injectable products "may pose risk for immunogenicity" and that there are "limited data in humans to inform safety-related considerations" [5].
- It isn't an approved drug.
How it compares with better-studied skincare
For context, some topical ingredients have stronger human evidence for visible skin aging:
- Retinol (vitamin A). In a randomized trial in 36 older adults (average age 87), a 0.4% retinol lotion applied to one arm for 24 weeks improved fine wrinkles compared with the same lotion without retinol on the other arm, with greater skin-matrix production [6].
- Oral collagen supplements are often mentioned alongside GHK-Cu. A 2025 meta-analysis of 23 randomized trials found that collagen's apparent benefits for hydration, elasticity and wrinkles disappeared in trials without industry funding, and in higher-quality trials [7].
The bottom line
- What's real: GHK is a real, naturally occurring molecule with consistent lab and animal findings, and it's a reasonable cosmetic ingredient.
- What the human evidence supports: limited, product-specific improvements in small topical studies.
- What it doesn't support: that GHK-Cu reliably reverses skin aging. Injecting it is unapproved, with little human safety information.
- Before trying it: if you're considering anything beyond a cosmetic product, talk to a dermatologist.
References
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. doi:10.1155/2015/648108
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19:1987. doi:10.3390/ijms19071987
- Mateescu DM, et al. GHK-Cu as a bioactive metallopeptide and drug-delivery cargo: coordination chemistry, formulation science, therapeutic evidence, and a translational roadmap. Pharmaceutics. 2026;18(9):1077. doi:10.3390/pharmaceutics18091077
- Yi KH, et al. Peptides in aesthetic dermatology: classification, fibroblast-centered mechanisms, delivery technologies, and clinical evidence. Life (Basel). 2026;16(10):1660. doi:10.3390/life16101660
- US Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. Content current as of 22 April 2026. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- Kafi R, et al. Improvement of naturally aged skin with vitamin A (retinol). Arch Dermatol. 2007;143:606-612. doi:10.1001/archderm.143.5.606
- Myung SK, et al. Effects of collagen supplements on skin aging: a systematic review and meta-analysis of randomized controlled trials. Am J Med. 2025. doi:10.1016/j.amjmed.2025.04.034